Претраживање
Приказ резултата 21-30 од 87
Toxicity of Organic and Inorganic Nickel in Pancreatic Cell Cultures: Comparison to Cadmium / Toksičnost organskog i neogranskog nikla u ćelijskim kulturama pankreasa: poređenje sa kadmijumom
(Pharmaceutical Association of Serbia, 2020)
Nickel compounds are Group 1 carcinogens and possibly cancer-causing in the pancreas. We examined the toxicity of nickel in both 2-D and 3-D pancreatic cell cultures, to determine the LD50 for organic and inorganic nickel ...
The emerging role of physiologically-based pharmacokinetic/biopharmaceutics modeling in formulation development / Uloga fiziološki-zasnovanog farmakokinetičkog/biofarmaceutskog modelovanja u razvoju farmaceutskih preparata
(Beograd : Savez farmaceutskih udruženja Srbije, 2021)
Computer-based (in silico) modeling & simulation tools have been embraced in different
fields of pharmaceutics for a variety of applications. Among these, physiologically-based
pharmacokinetic/biopharmaceutics modeling ...
Relevance and evaluation of the benchmark dose in toxicology / Značaj i procena benchmark doze u toksikologiji
(Beograd : Savez farmaceutskih udruženja Srbije, 2020)
This paper aims to present the importance of the benchmark dose (BMD) as a point of departure (the lowest dose or concentration in the experiment that deviates from the response that differs from the normal ...
Telomere length as a biomarker of aging and diseases / Dužina telomera kao biomarker starenja i bolesti
(Beograd : Savez farmaceutskih udruženja Srbije, 2022)
As research related to healthspan and lifespan has become a hot topic, the necessity for a
reliable and practical biomarker of aging (BoA), which can provide information about mortality
and morbidity risk, along with ...
Biomarkers of dyslipidemia in patients with diabetic foot / Biomarkeri dislipidemije kod pacijenata sa dijabetesnim stopalom
(Beograd : Savez farmaceutskih udruženja Srbije, 2022)
Diabetic foot (DF) is one of the most severe complications of diabetes that significantly
reduces the quality of life and survival of patients. Besides firmly established risk factors, novel
data indicate that alterations ...
Docking studies of some pyrazole containing compounds in the cyclooxygenase-2 active site / Doking studije nekih jedinjenja sa pirazolom u aktivnom mestu ciklooksigenaze-2
(Savez farmaceutskih udruženja Srbije (SFUS), 2023)
Whereas nonselective nonsteroidal anti-inflammatory drugs, such as aspirin, ibuprofen and
diclofenac, inhibit both cyclooxygenase-1 and cyclooxigenase-2 enzymes, selective inhibitors
target cyclooxygenase-2, which is ...
Does Pentraxin-3 contribute to the reduction of low-density lipoprotein levels by statin therapy? / Da li pentraksin -3 doprinosi sniženju koncentracije lipoproteina niske gustine i terapiji statinima?
(Pharmaceutical Association of Serbia, 2022)
Statins have been shown to decrease inflammatory markers, especially high sensitivity C reactive protein (hsCRP), in a dose-dependent manner. Pentraxin-3 (PTX3) is another important inflammatory biomarker from the pentraxin ...
Biomarkers of aging-associated chronic inflammation as a prognostic factor for human longevity / Biomarkeri hronične inflamacije povezane sa starenjem kao prediktora dužine života
(Beograd : Savez farmaceutskih udruženja Srbije, 2022)
It has been well-established that age-associated low-grade chronic inflammation
contributes to the development of a spectrum of chronic diseases, including diabetes mellitus,
ischemic heart disease, stroke, cancer, chronic ...
White blood cell count, its subsets, and their indexes in type 2 diabetes mellitus / Ukupan broj leukocita, diferencijalna krvna slika i njihovi indeksi u diabetes mellitus-u tip 2
(Beograd : Savez farmaceutskih udruženja Srbije, 2022)
Due to the increased prevalence of obesity-related complications, especially type 2 diabetes
mellitus (DM2), great attention has been paid to the variety of adipokines and cytokines, i.e.
biomarkers, which are secreted ...
Development and validation of a stability- indicating RP-HPLC method for determination of aripiprazole and its degradation products / Razvoj i validacija RP-HPLC metode za praćenje stabilnosti u cilju određivanja sadržaja aripiprazola i njegovih degradacionih proizvoda
(Savez farmaceutskih udruženja Srbije (SFUS), 2023)
The goal of this study was the optimization of chromatographic conditions and validation
of the isocratic RP-HPLC method for monitoring the stability of aripiprazole, identification and
quantitative analysis of aripiprazole ...